263 related articles for article (PubMed ID: 15671064)
1. RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome.
Gruber J; Lampe T; Osborn M; Weber K
J Cell Sci; 2005 Feb; 118(Pt 4):689-96. PubMed ID: 15671064
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of multiple forms of lamin A with down-regulation of FACE-1 suppresses growth in senescent human cells.
Ukekawa R; Miki K; Fujii M; Hirano H; Ayusawa D
Genes Cells; 2007 Mar; 12(3):397-406. PubMed ID: 17352743
[TBL] [Abstract][Full Text] [Related]
3. The truncated prelamin A in Hutchinson-Gilford progeria syndrome alters segregation of A-type and B-type lamin homopolymers.
Delbarre E; Tramier M; Coppey-Moisan M; Gaillard C; Courvalin JC; Buendia B
Hum Mol Genet; 2006 Apr; 15(7):1113-22. PubMed ID: 16481358
[TBL] [Abstract][Full Text] [Related]
4. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS.
Denecke J; Brune T; Feldhaus T; Robenek H; Kranz C; Auchus RJ; Agarwal AK; Marquardt T
Hum Mutat; 2006 Jun; 27(6):524-31. PubMed ID: 16671095
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.
Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497
[TBL] [Abstract][Full Text] [Related]
6. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
7. Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging.
Ragnauth CD; Warren DT; Liu Y; McNair R; Tajsic T; Figg N; Shroff R; Skepper J; Shanahan CM
Circulation; 2010 May; 121(20):2200-10. PubMed ID: 20458013
[TBL] [Abstract][Full Text] [Related]
8. [A-type lamins and progeroïd syndromes : persistent farnesylation with dramatic effects].
Navarro CL; Poitelon Y; Lévy N
Med Sci (Paris); 2008 Oct; 24(10):833-40. PubMed ID: 18950579
[TBL] [Abstract][Full Text] [Related]
9. Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice.
Fong LG; Ng JK; Meta M; Coté N; Yang SH; Stewart CL; Sullivan T; Burghardt A; Majumdar S; Reue K; Bergo MO; Young SG
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18111-6. PubMed ID: 15608054
[TBL] [Abstract][Full Text] [Related]
10. Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors.
Navarro CL; Cadiñanos J; De Sandre-Giovannoli A; Bernard R; Courrier S; Boccaccio I; Boyer A; Kleijer WJ; Wagner A; Giuliano F; Beemer FA; Freije JM; Cau P; Hennekam RC; López-Otín C; Badens C; Lévy N
Hum Mol Genet; 2005 Jun; 14(11):1503-13. PubMed ID: 15843403
[TBL] [Abstract][Full Text] [Related]
11. Compound heterozygous ZMPSTE24 mutations reduce prelamin A processing and result in a severe progeroid phenotype.
Shackleton S; Smallwood DT; Clayton P; Wilson LC; Agarwal AK; Garg A; Trembath RC
J Med Genet; 2005 Jun; 42(6):e36. PubMed ID: 15937076
[No Abstract] [Full Text] [Related]
12. Quantitative analysis of localization and nuclear aggregate formation induced by GFP-lamin A mutant proteins in living HeLa cells.
Hübner S; Eam JE; Wagstaff KM; Jans DA
J Cell Biochem; 2006 Jul; 98(4):810-26. PubMed ID: 16440304
[TBL] [Abstract][Full Text] [Related]
13. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
14. Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells.
Kandert S; Lüke Y; Kleinhenz T; Neumann S; Lu W; Jaeger VM; Munck M; Wehnert M; Müller CR; Zhou Z; Noegel AA; Dabauvalle MC; Karakesisoglou I
Hum Mol Genet; 2007 Dec; 16(23):2944-59. PubMed ID: 17881656
[TBL] [Abstract][Full Text] [Related]
15. Nuclear protein import is reduced in cells expressing nuclear envelopathy-causing lamin A mutants.
Busch A; Kiel T; Heupel WM; Wehnert M; Hübner S
Exp Cell Res; 2009 Aug; 315(14):2373-85. PubMed ID: 19442658
[TBL] [Abstract][Full Text] [Related]
16. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834
[TBL] [Abstract][Full Text] [Related]
17. N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
Bifulco M; D'Alessandro A; Paladino S; Malfitano AM; Notarnicola M; Caruso MG; Laezza C
FEBS J; 2013 Dec; 280(23):6223-32. PubMed ID: 24112551
[TBL] [Abstract][Full Text] [Related]
18. Tethering by lamin A stabilizes and targets the ING1 tumour suppressor.
Han X; Feng X; Rattner JB; Smith H; Bose P; Suzuki K; Soliman MA; Scott MS; Burke BE; Riabowol K
Nat Cell Biol; 2008 Nov; 10(11):1333-40. PubMed ID: 18836436
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of distinct prelamin A variants in human diploid fibroblasts differentially affects cell homeostasis.
Candelario J; Borrego S; Reddy S; Comai L
Exp Cell Res; 2011 Feb; 317(3):319-29. PubMed ID: 20974128
[TBL] [Abstract][Full Text] [Related]
20. Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors.
Rusiñol AE; Sinensky MS
J Cell Sci; 2006 Aug; 119(Pt 16):3265-72. PubMed ID: 16899817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
